SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $1,481,000 | +3.9% | 207,400 | -5.1% | 0.00% | -50.0% |
Q2 2014 | $1,425,000 | -7.0% | 218,570 | -5.7% | 0.00% | 0.0% |
Q1 2014 | $1,532,000 | +2846.2% | 231,700 | +2106.7% | 0.00% | – |
Q3 2013 | $52,000 | -93.1% | 10,500 | -92.7% | 0.00% | -100.0% |
Q2 2013 | $751,000 | – | 144,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |